Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

Senior leaders at the US Food and Drug Administration began pushing Moderna Inc. and Pfizer Inc. to file for full, formal ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Moderna previously reported a summary of ... asking the company to run a new clinical trial of its protein-based COVID-19 vaccine after the agency grants full approval, sowing uncertainty about ...